Desentum on suomalainen, tutkimuslähtöinen biolääkeyritys, joka kehittää uudentyyppisiä tuott
Location: Finland, Mainland Finland, Helsinki
Employees: 11-50
Total raised: $22.04M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Cascara ve... | cascaraven... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.02.2024 | - | $12.97M | - |
| 21.01.2022 | - | $9.07M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 20.02.2024 | Finland’s Desentum bags €12M to boost allergy vaccine develo... | Read this article in: Espoo-based Desentum, a biopharmaceutical company, announced that it has raise... | siliconcan... |
| 20.02.2024 | Finland’s Desentum raises €12M to advance allergy vaccine de... | Finland’s Desentum raises €12M to advance allergy vaccine development 20 February, 2024, 17:11 Ros... | ain.capita... |
| 21.01.2022 | Desentum raised 8 M€ to advance clinical development of lead... | Desentum raised 8 M€ to advance clinical development of lead allergy vaccine candidate Fri, Jan 21, ... | news.cisio... |
| 21.01.2022 | Finland’s Desentum raises €8M to develop novel types of alle... | Allergy is one of the most common chronic conditions in Europe. Currently, over 150 million European... | siliconcan... |
| 25.10.2021 | Desentum reports positive findings for the First-in-Human cl... | Desentum reports positive findings for the First-in-Human clinical study of lead product candidate i... | news.cisio... |
| - | Desentum | “Desentum is a biopharmaceutical company developing novel types of allergen immunotherapy products (... | fastfounde... |